Lyell Immunopharma Inc (NASDAQ:LYEL)

3.99
Delayed Data
As of May 13
 -0.12 / -2.92%
Today’s Change
3.95
Today|||52-Week Range
19.84
-48.45%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Lyell Immunopharma Inc have a median target of 15.50, with a high estimate of 21.00 and a low estimate of 15.00. The median estimate represents a +288.47% increase from the last price of 3.99.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Lyell Immunopharma Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.28
Sales
$776.5K
Reporting Date
Jun 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 20.71%
 
 
 
 
 
 
Growthannually 29.06%
 
 
 

Sales

Growthquarterly -72.48%
 
 
 
 
 
 
Growthannually 100.48%
 
 
 
Key to the earnings and sales forecast charts.